Nektar Therapeutics (NASDAQ:NKTR)
CAPS Rating:
A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines.
RSS Headlines
Fool UK